• News
  • Finance

AstraZeneca Rejects Sweetened Pfizer Offer of $106.5 Billion

May 2 (Bloomberg) -- AstraZeneca Plc rejected Pfizer Inc.ís sweetened takeover proposal, saying the 63.1 billion-pound ($106.5 billion) offer fails to appreciate the value of the promising medicines under development by the U.K.ís second- biggest drugmaker.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!